Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Kornélia Polyák, Charles Y. Lin et al.|Nature|2016Cited by 629
A pathology foundation model for cancer diagnosis and prognosis predictionXiyue Wang, Kun‐Hsing Yu, Junhan Zhao et al.|Nature|2024Cited by 445
Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineagesJennifer M. Rosenbluth, Joan S. Brugge, Ron C.J. Schackmann et al.|Nature Communications|2020Cited by 273
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K. Mehta, Jennifer L. Guerriero, Emily Cheney et al.|Nature Cancer|2020Cited by 271
Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysisDavid Calligaris, Nathalie Y.R. Agar, Andrea L. Richardson et al.|Proceedings of the National Academy of Sciences|2014Cited by 244